Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H10N4O5 |
| Molecular Weight | 242.1888 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)N(CCO)\N=C\C1=CC=C(O1)[N+]([O-])=O
InChI
InChIKey=FJVAAURIDNIYAE-BJMVGYQFSA-N
InChI=1S/C8H10N4O5/c9-8(14)11(3-4-13)10-5-6-1-2-7(17-6)12(15)16/h1-2,5,13H,3-4H2,(H2,9,14)/b10-5+
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The effect of furadroxyl treatment and x-irradiation on the hyaluronidase concentration of rat testes. | 1957-01 |
|
| Pyruvate oxidation in testicular tissues during furadroxyl-induced spermatogenic arrest. | 1955-06 |
|
| The use of 5-nitro-2-furaldehyde-2(2-hydroxyethyl) semicarbazone (furadroxyl) in the treatment of experimental trypanosomiasis in laboratory animals. | 1953-04 |
|
| [Antibacterial action of neomycin and furadroxyl in vitro and in vivo]. | 1950-06-26 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C28394
Created by
admin on Wed Apr 02 08:29:45 GMT 2025 , Edited by admin on Wed Apr 02 08:29:45 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
206-970-3
Created by
admin on Wed Apr 02 08:29:45 GMT 2025 , Edited by admin on Wed Apr 02 08:29:45 GMT 2025
|
PRIMARY | |||
|
6474
Created by
admin on Wed Apr 02 08:29:45 GMT 2025 , Edited by admin on Wed Apr 02 08:29:45 GMT 2025
|
PRIMARY | |||
|
100000084401
Created by
admin on Wed Apr 02 08:29:45 GMT 2025 , Edited by admin on Wed Apr 02 08:29:45 GMT 2025
|
PRIMARY | |||
|
C84014
Created by
admin on Wed Apr 02 08:29:45 GMT 2025 , Edited by admin on Wed Apr 02 08:29:45 GMT 2025
|
PRIMARY | |||
|
693
Created by
admin on Wed Apr 02 08:29:45 GMT 2025 , Edited by admin on Wed Apr 02 08:29:45 GMT 2025
|
PRIMARY | |||
|
SUB09252MIG
Created by
admin on Wed Apr 02 08:29:45 GMT 2025 , Edited by admin on Wed Apr 02 08:29:45 GMT 2025
|
PRIMARY | |||
|
405-22-1
Created by
admin on Wed Apr 02 08:29:45 GMT 2025 , Edited by admin on Wed Apr 02 08:29:45 GMT 2025
|
PRIMARY | |||
|
3794
Created by
admin on Wed Apr 02 08:29:45 GMT 2025 , Edited by admin on Wed Apr 02 08:29:45 GMT 2025
|
PRIMARY | |||
|
YN9DMN3CVQ
Created by
admin on Wed Apr 02 08:29:45 GMT 2025 , Edited by admin on Wed Apr 02 08:29:45 GMT 2025
|
PRIMARY | |||
|
DTXSID701015578
Created by
admin on Wed Apr 02 08:29:45 GMT 2025 , Edited by admin on Wed Apr 02 08:29:45 GMT 2025
|
PRIMARY | |||
|
9570072
Created by
admin on Wed Apr 02 08:29:45 GMT 2025 , Edited by admin on Wed Apr 02 08:29:45 GMT 2025
|
PRIMARY | |||
|
CHEMBL92444
Created by
admin on Wed Apr 02 08:29:45 GMT 2025 , Edited by admin on Wed Apr 02 08:29:45 GMT 2025
|
PRIMARY | |||
|
m366
Created by
admin on Wed Apr 02 08:29:45 GMT 2025 , Edited by admin on Wed Apr 02 08:29:45 GMT 2025
|
PRIMARY | Merck Index |
ACTIVE MOIETY